This paper is in the following e-collection/theme issue:

Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (832) Breast Cancer (206) Electronic Health Records (1053)

Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43359, first published .
Preliminary Attainability Assessment of Real-World Data for Answering Major Clinical Research Questions in Breast Cancer Brain Metastasis: Framework Development and Validation Study

Preliminary Attainability Assessment of Real-World Data for Answering Major Clinical Research Questions in Breast Cancer Brain Metastasis: Framework Development and Validation Study

Preliminary Attainability Assessment of Real-World Data for Answering Major Clinical Research Questions in Breast Cancer Brain Metastasis: Framework Development and Validation Study

Authors of this article:

Min Jeong Kim1 Author Orcid Image ;   Hyo Jung Kim1, 2 Author Orcid Image ;   Danbee Kang3, 4 Author Orcid Image ;   Hee Kyung Ahn5 Author Orcid Image ;   Soo-Yong Shin1, 2, 6 Author Orcid Image ;   Seri Park7 Author Orcid Image ;   Juhee Cho3, 4, 8 Author Orcid Image ;   Yeon Hee Park1, 9 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics

Min Jeong Kim   1 * , MSc ;   Hyo Jung Kim   1, 2 * , PhD ;   Danbee Kang   3, 4 , PhD ;   Hee Kyung Ahn   5 , MD ;   Soo-Yong Shin   1, 2, 6 , PhD ;   Seri Park   7 , BSN ;   Juhee Cho   3, 4, 8 , PhD ;   Yeon Hee Park   1, 9 , MD, PhD

1 Department of Digital Health, Samsung Advanced Institute for Health Science & Technology, Sungkyunkwan University, Seoul, Republic of Korea

2 Center for Research Resource Standardization, Research Institution for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

3 Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

4 Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Science & Technology, Sungkyunkwan University, Seoul, Republic of Korea

5 Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea

6 Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, Republic of Korea

7 Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea

8 Department of Epidemiology and Medicine, The Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

9 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

*these authors contributed equally

Corresponding Author:

  • Yeon Hee Park, MD, PhD
  • Division of Hematology-Oncology
  • Department of Medicine, Samsung Medical Center
  • Sungkyunkwan University School of Medicine
  • 81, Ilwon-ro
  • Gangnam-gu
  • Seoul, 06351
  • Republic of Korea
  • Phone: 82 10-9933-1780
  • Email: yhparkhmo@skku.edu